Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: A preliminary report on an active regimen

被引：0
|
作者：
Georgoulias, V
Kourousis, C
Kakolyris, S
Androulakis, N
Dimopoulos, MA
Papadakis, E
Kotsakis, T
Vardakis, N
Kalbakis, K
Merambeliotakis, N
Hatzidaki, D
机构：
[1] UNIV CRETE, DEPT MED ONCOL, IRAKLION, GREECE
[2] UNIV ATHENS, DEPT CLIN THERAPEUT, ATHENS, GREECE
[3] SOTIRIA GEN HOSP CHEST DIS ATHENS, DEPT PULM MED 1, ATHENS, GREECE
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 66
页数：6
相关论文
共 50 条
  • [21] Docetaxel as Second-line Monotherapy for Advanced Non-small Cell Lung Cancer
    Kang, Hyun Mo
    Lee, Jeong Eun
    Jang, Pil Soon
    Lee, Yun Sun
    Kwon, Sun Jung
    An, Jin Young
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 58 (05) : 465 - 472
  • [22] Gemcitabine as second-line treatment for advanced non-small-cell lung cancer:: A phase II trial
    Crinò, L
    Mosconi, AM
    Scagliotti, G
    Selvaggi, G
    Novello, S
    Rinaldi, M
    Della Giulia, M
    Gridelli, C
    Rossi, A
    Calandri, C
    De Marinis, F
    Noseda, M
    Tonato, M
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2081 - 2085
  • [23] A preliminary report of a phase II trial of single-agent vinflunine as second-line treatment of advanced non-small cell lung cancer
    Joppert, M.
    Boccia, R.
    Dakhil, S.
    Steis, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Mori, K.
    Kamiyama, Y.
    Kondo, T.
    Kodama, T.
    EJC SUPPLEMENTS, 2007, 5 (04): : 393 - 393
  • [25] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 189 - 195
  • [26] Epirubicin plus Paclitaxel Regimen as Second-line Treatment of Patients with Small-cell Lung Cancer
    Pasello, Giulia
    Carli, Paolo
    Canova, Fabio
    Bonanno, Laura
    Polo, Valentina
    Zago, Giulia
    Urso, Loredana
    Conte, Pierfranco
    Favaretto, Adolfo
    ANTICANCER RESEARCH, 2015, 35 (04) : 2183 - 2189
  • [27] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kondo, Tetsuro
    Kano, Yasuhiko
    Kodama, Tetsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (02) : 189 - 195
  • [28] Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane plus platinum regimens
    Coskun, Ugur
    Kaya, Ali Osman
    Buyukberber, Sueleyman
    Benekli, Mustafa
    Uner, Aytug
    Dikilitas, Mustafa
    Ozturk, Banu
    Yildiz, Ramazan
    Ozkan, Secil
    Yaman, Emel
    Yamac, Deniz
    MEDICAL ONCOLOGY, 2008, 25 (02) : 133 - 136
  • [29] Single agents in the second-line treatment of non-small cell lung cancer
    Belani, CP
    SEMINARS IN ONCOLOGY, 1998, 25 (03) : 10 - 14
  • [30] Geographic variation in the second-line treatment of non-small cell lung cancer
    Edelman, MJ
    Sekine, I
    Tamura, T
    Saijo, N
    SEMINARS IN ONCOLOGY, 2006, 33 (01) : S39 - S44
12345